712 related articles for article (PubMed ID: 18492291)
1. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line.
Nishimura Y; Yoshioka K; Bereczky B; Itoh K
Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291
[TBL] [Abstract][Full Text] [Related]
2. The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.
Nishimura Y; Bereczky B; Ono M
Histochem Cell Biol; 2007 May; 127(5):541-53. PubMed ID: 17361439
[TBL] [Abstract][Full Text] [Related]
3. Silencing of SNX1 by siRNA stimulates the ligand-induced endocytosis of EGFR and increases EGFR phosphorylation in gefitinib-resistant human lung cancer cell lines.
Nishimura Y; Takiguchi S; Yoshioka K; Nakabeppu Y; Itoh K
Int J Oncol; 2012 Oct; 41(4):1520-30. PubMed ID: 22859339
[TBL] [Abstract][Full Text] [Related]
4. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196
[TBL] [Abstract][Full Text] [Related]
5. Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line.
Nishimura Y; Takiguchi S; Ito S; Itoh K
Int J Oncol; 2014 Feb; 44(2):412-26. PubMed ID: 24297483
[TBL] [Abstract][Full Text] [Related]
6. A novel role of Rho-kinase in the regulation of ligand-induced phosphorylated EGFR endocytosis via the early/late endocytic pathway in human fibrosarcoma cells.
Nishimura Y; Bereczky B; Yoshioka K; Taniguchi S; Itoh K
J Mol Histol; 2011 Oct; 42(5):427-42. PubMed ID: 21847509
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M
Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990
[TBL] [Abstract][Full Text] [Related]
8. Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells.
Nishimura Y; Hyuga S; Takiguchi S; Hyuga M; Itoh K; Hanawa T
Int J Oncol; 2016 May; 48(5):1895-906. PubMed ID: 26983447
[TBL] [Abstract][Full Text] [Related]
9. TIP30 overcomes gefitinib resistance by regulating cytoplasmic and nuclear EGFR signaling in non-small-cell lung cancer.
Shuai S; Liao X; Wang H; Liu L; Mei S; Cao J; Wang S
Cancer Sci; 2021 Oct; 112(10):4139-4150. PubMed ID: 34058054
[TBL] [Abstract][Full Text] [Related]
10. Involvement of SNX1 in regulating EGFR endocytosis in a gefitinib-resistant NSCLC cell lines.
Nishimura Y; Itoh K
Cancer Drug Resist; 2019; 2(3):539-549. PubMed ID: 35582586
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor and membrane trafficking. EGF receptor activation of endocytosis requires Rab5a.
Barbieri MA; Roberts RL; Gumusboga A; Highfield H; Alvarez-Dominguez C; Wells A; Stahl PD
J Cell Biol; 2000 Oct; 151(3):539-50. PubMed ID: 11062256
[TBL] [Abstract][Full Text] [Related]
12. LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells.
Nishimura Y; Yoshioka K; Bernard O; Himeno M; Itoh K
Eur J Cell Biol; 2004 Aug; 83(7):369-80. PubMed ID: 15503860
[TBL] [Abstract][Full Text] [Related]
13. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF.
Oksvold MP; Skarpen E; Wierød L; Paulsen RE; Huitfeldt HS
Eur J Cell Biol; 2001 Apr; 80(4):285-94. PubMed ID: 11370743
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells.
Oksvold MP; Skarpen E; Lindeman B; Roos N; Huitfeldt HS
J Histochem Cytochem; 2000 Jan; 48(1):21-33. PubMed ID: 10653583
[TBL] [Abstract][Full Text] [Related]
15. Engagement of the small GTPase Rab31 protein and its effector, early endosome antigen 1, is important for trafficking of the ligand-bound epidermal growth factor receptor from the early to the late endosome.
Chua CE; Tang BL
J Biol Chem; 2014 May; 289(18):12375-89. PubMed ID: 24644286
[TBL] [Abstract][Full Text] [Related]
16. EGF receptor lysosomal degradation is delayed in the cells stimulated with EGF-Quantum dot bioconjugate but earlier key events of endocytic degradative pathway are similar to that of native EGF.
Salova AV; Belyaeva TN; Leontieva EA; Kornilova ES
Oncotarget; 2017 Jul; 8(27):44335-44350. PubMed ID: 28574831
[TBL] [Abstract][Full Text] [Related]
17. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors.
Minakata K; Takahashi F; Nara T; Hashimoto M; Tajima K; Murakami A; Nurwidya F; Yae S; Koizumi F; Moriyama H; Seyama K; Nishio K; Takahashi K
Cancer Sci; 2012 Nov; 103(11):1946-54. PubMed ID: 22863020
[TBL] [Abstract][Full Text] [Related]
19. Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells.
Fujiwara R; Taniguchi Y; Rai S; Iwata Y; Fujii A; Fujimoto K; Kumode T; Serizawa K; Morita Y; Espinoza JL; Tanaka H; Hanamoto H; Matsumura I
Biochem Biophys Res Commun; 2022 Oct; 626():156-166. PubMed ID: 35994825
[TBL] [Abstract][Full Text] [Related]
20. rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome.
Ceresa BP; Bahr SJ
J Biol Chem; 2006 Jan; 281(2):1099-106. PubMed ID: 16282324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
